[1] Avison M J, Nath A, Greene-Avison R, et al. Neuroimaging correlates of HIV-associated BBB compromise[J]. J Neuroimmunol, 2004, 157(1-2):140-146. [2] Antinori A, Arendt G, Becker J T, et al. Updated research nosology for HIV-associated neurocognitive disorders[J]. Neurology,2007,69(18):1789-1799. [3] Gray F, Adle-Biassette H, Chretien F, et al. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments[J]. Clin Neuropathol, 2001, 20(4):146-155. [4] Nakazato A, Tominaga D, Tasato D, et al. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?[J]. J Infect Chemother, 2014, 20(3):217-219. [5] Letendre S L, Ellis R J, Everall I, et al. Neurologic complications of HIV disease and their treatment[J]. Top HIV Med, 2009, 17(2):46-56. [6] Satishchandra P, Nalini A, Gourie-Devi M, et al. Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96)[J]. Indian J Med Res, 2000, 111(1):14-23. [7] Adle‐Biassette H, Levy Y, Colornbel M, et al. Neuronal apoptosis in HIV infection in adults[J]. Neuropathol Appl Neurobiol, 1995, 21(3):218-227. [8] Wadia R S, Pujari S N, Kothari S, et al. Neurological manifestations of HIV disease[J]. J Assoc Physicians India, 2001, 49(2):343-348. [9] Kaul M, Garden G A, Lipton S A. Pathways to neuronal injury and apoptosis in HIV-associated dementia[J]. Nature, 2001, 410(6831):988-994. [10] Jayadev S, Garden G A. Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders[J]. J Neuroimmune Pharmacol, 2009, 4(2):175-189. [11] Masliah E, Heaton R K, Marcohe T D, et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders[J]. Ann Neurol, 1997, 42(6):963-972. [12] Steinbrink F, Evers S, Buerke B, et al. Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration[J]. Eur J Neurol, 2012, 20(3):420-428. [13] McArthur J C, Haughey N, Gartner S, et al. Human immunodeficiency virus-associated dementia: an evolving disease[J]. J Neurovirol, 2003, 9(2):205-221. [14] Masters M C, Ances B M. Role of neuroimaging in HIV-associated neurocognitive disorders[J]. Semin Neurol, 2014, 34(1):89-102. [15] Aylward E H, Henderer J D, Mcarthur J C, et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging[J]. Neurology, 1993, 43(10):2099-2104. [16] Corrêa D G, Zimmermann N, Netto T M, et al. Regional cerebral gray matter volume in HIV-Positive patients with executive function deficits[J]. J Neuroimaging, 2016,26(4):450-457. [17] Wade B S, Valcour V G, Wendelken-Riegelhaupt L, et al. Mapping abnormal subcortical brain morphometry in an elderly HIV+cohort[J]. Proceedings, 2015,2015: 917-975. [18] Sarma M K, Nagarajan R, Keller M A, et al. Regional brain gray and white matter changes in perinatally HIV-infected adolescents[J]. Neuroimage Clin, 2014, 4:29-34. [19] Heaps J M, Sithinamsuwan P, Paul R, et al. Association between brain volumes and HAND in cART-nave HIV+individuals from Thailand[J]. J Neurovirol, 2015, 21(2):105-112. [20] Bonnet F, Amieva H, Marquant F, et al. Cognitive disorders in HIV-infected patients: are they HIV-related?[J]. AIDS, 2013, 27(3):391-400. [21] Du H, Wu Y, Ochs R, et al. A comparative evaluation of quantitative neuroimaging measurements of brain status in HIV infection[J]. Psychiatry Res, 2012, 203(1):95-99. [22] Ogawa S, Lee T, Nayak A S, et al. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields[J]. Magn Reson Med, 1990, 14(1):68-78. [23] Biswal B B. Resting state fMRI: a personal history[J]. Neuroimage, 2012, 62(2):938-944. [24] Buckner R L, Andrews-Hanna J R, Schacter D L. The brain's default network: anatomy, function, and relevance to disease[J]. Ann N Y Acad Sci, 2008, 1124(10):1-38. [25] Müller R A, Shih P, Keehn B, et al. Underconnected, but how?A survey of functional connectivity MRI studies in autism spectrum disorders[J]. Cereb Cortex, 2011, 21(10):2233-2243. [26] Ernst T, Chang L, Jovicich J, et al. Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients[J]. Neurology, 2002, 59(9):1343-1349. [27] Ances B M, Roc A C, Korczykowski M, et al. Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients[J]. J Neurovirol, 2008, 14(5):418-424. [28] Archibald S L, Jacobson M W, Fennema-Notestine C, et al. Functional interactions of HIV-infection and methamphetamine dependence during motor programming[J]. Psychiatry Res, 2012, 202(1):46-52. [29] Juengst S B, Aizenstein H J, Figurski J, et al. Alterations in the hemodynamic response function in cognitively impaired HIV/AIDS subjects[J]. J Neurosci Methods, 2007, 163(2):208-212. [30] Chang L, Tomasi D, Yakupov R, et al. Adaptation of the attention network in human immunodeficiency virus brain injury[J]. Ann Neurol, 2004, 56(2):259-272. [31] Chang L, Holt J L, Yakupov R, et al. Lower cognitive reserve in the aging human immunodeficiency virus-infected brain[J]. Neurobiol Aging, 2013, 34(4):1240-1253. [32] Bird R B, Stewart W E, Lightfoot E N. Transport Phenomena[M]. New York:John Wiley & Sons, 1960. [33] Hagmann P, Jonasson L, Maeder P, et al. Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond[J]. Radiographics, 2006, 26 Suppl 1(4):S205-S223. [34] Towgood K J, Pitkanen M, Kulasegaram R, et al. Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities[J]. Cortex, 2012, 48(2):230-241. [35] Xuan A, Wang G B, Shi D P, et al. Initial study of magnetic resonance diffusion tensor imaging in brain white matter of early AIDS patients[J]. Chin Med J, 2013, 126(14):2720-2724. [36] Zhu T, Zhong J, Hu R, et al. Patterns of white matter injury in HIV infection after partial immune reconstitution: a DTI tract-based spatial statistics study[J]. J Neurovirol, 2013, 19(1):10-23. [37] Leite S C, Corrêa D G, Doring T M, et al. Diffusion tensor MRI evaluation of the corona radiata, cingulate gyri, and corpus callosum in HIV patients[J]. J Magn Reson Imaging, 2013, 38(6):1488-1493. [38] Ipser J C, Brown G G, Bischoff-Grethe A, et al. HIV infection is associated with attenuated frontostriatal intrinsic connectivity: a preliminary study[J]. J Int Neuropsychol Soc, 2015, 21(3):203-213. [39] Chen Y, An H, Zhu H, et al. White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+patients[J]. Neuroimage, 2009, 47(4):1154-1162. [40] Stebbins G T, Smith C A, Bartt R E, et al. HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study[J]. J Acquir Immune Defic Syndr, 2007, 46(5):564-573. [41] Wu Y, Storey P, Cohen B A, et al. Diffusion alterations in corpus callosum of patients with HIV[J]. AJNR Am J Neuroradiol, 2006, 27(3):656-660. [42] Chang L, Wong V, Nakama H, et al. Greater than age-related changes in brain diffusion of HIV patients after 1 year[J]. J Neuroimmune Pharmacol, 2008, 3(4):265-274. [43] Thurnher M M, Castillo M, Stadler A, et al. Diffusion-tensor MR imaging of the brain in human immunodeficiency virus-positive patients[J]. AJNR Am J Neuroradiol, 2005, 26(9):2275-2281. [44] Brady T J, Wismer G L, Buxton R, et al. Magnetic resonance chemical shift imaging[J]. Magn Reson Annu, 1986: 55-80. [45] Sailasuta N, Ananworanich J, Lerdlum S, et al. Neuronal-glia markers by magnetic resonance spectroscopy in HIV before and after combination antiretroviral therapy[J]. J Acquir Immune Defic Syndr, 2016, 71(1):24-30. |